| 000 | 01548 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512021102.0 | ||
| 264 | 0 | _c19891221 | |
| 008 | 198912s 0 0 eng d | ||
| 022 | _a0019-9567 | ||
| 024 | 7 |
_a10.1128/iai.57.12.3743-3750.1989 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeinstein, D L | |
| 245 | 0 | 0 |
_aIn vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. _h[electronic resource] |
| 260 |
_bInfection and immunity _cDec 1989 |
||
| 300 |
_a3743-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aBacterial Toxins _xgenetics |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCells, Cultured _xdrug effects |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aGenetic Complementation Test |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMacromolecular Substances |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRestriction Mapping |
| 650 | 0 | 4 | _aShiga Toxin 1 |
| 650 | 0 | 4 | _aShiga Toxin 2 |
| 650 | 0 | 4 | _aShiga Toxins |
| 650 | 0 | 4 | _aShigella |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aJackson, M P | |
| 700 | 1 | _aPerera, L P | |
| 700 | 1 | _aHolmes, R K | |
| 700 | 1 | _aO'Brien, A D | |
| 773 | 0 |
_tInfection and immunity _gvol. 57 _gno. 12 _gp. 3743-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/iai.57.12.3743-3750.1989 _zAvailable from publisher's website |
| 999 |
_c2813412 _d2813412 |
||